Preclinical Safety

Our extensive past experience in a Big Pharma environment and current collaborations and contract research services with Biotech companies and the Academic sector supports our High Capacity Preclinical Assay Platform andassessment services.


This Preclinical Integrated solution follows Pharmaceutical industry standards applied to high throughput preclinical studies for a complete in vitro/in vivo Safety/Efficacy studies.


Our facilities are state-of-the-art guaranteeing fast turn-around times due to the high automation of the screening platform.


We address preclinical issues by identifying potential liabilities of new leads in the early stages of the Drug Discovery process:

Mitochondrial Toxicity




MEDINA and Neuron BPh have reached an agreementto jointly publicize their technologies andpre-clinical integrated platform for the pharmaceutical industry.